dyAb: Flow Matching for Flexible Antibody Design with AlphaFold-driven Pre-binding Antigen
By: Cheng Tan , Yijie Zhang , Zhangyang Gao and more
Potential Business Impact:
Designs better medicines by predicting how they change.
The development of therapeutic antibodies heavily relies on accurate predictions of how antigens will interact with antibodies. Existing computational methods in antibody design often overlook crucial conformational changes that antigens undergo during the binding process, significantly impacting the reliability of the resulting antibodies. To bridge this gap, we introduce dyAb, a flexible framework that incorporates AlphaFold2-driven predictions to model pre-binding antigen structures and specifically addresses the dynamic nature of antigen conformation changes. Our dyAb model leverages a unique combination of coarse-grained interface alignment and fine-grained flow matching techniques to simulate the interaction dynamics and structural evolution of the antigen-antibody complex, providing a realistic representation of the binding process. Extensive experiments show that dyAb significantly outperforms existing models in antibody design involving changing antigen conformations. These results highlight dyAb's potential to streamline the design process for therapeutic antibodies, promising more efficient development cycles and improved outcomes in clinical applications.
Similar Papers
AbFlowNet: Optimizing Antibody-Antigen Binding Energy via Diffusion-GFlowNet Fusion
Machine Learning (CS)
Designs better antibodies that stick to targets.
Benchmark for Antibody Binding Affinity Maturation and Design
Quantitative Methods
Finds better ways to make medicines.
FP-AbDiff: Improving Score-based Antibody Design by Capturing Nonequilibrium Dynamics through the Underlying Fokker-Planck Equation
Machine Learning (CS)
Creates better medicines by designing perfect antibody shapes.